Distribution of tumor-infiltrating immune cells in glioblastoma

Descripción del Articulo

Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor- infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analys...

Descripción completa

Detalles Bibliográficos
Autor: Castaneda, Carlos A.
Formato: artículo
Fecha de Publicación:2018
Institución:Universidad Privada San Juan Bautista
Repositorio:UPSJB-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.upsjb.edu.pe:upsjb/2646
Enlace del recurso:http://repositorio.upsjb.edu.pe/handle/upsjb/2646
Nivel de acceso:acceso abierto
Materia:Biomarcador
Glioblastoma
Macrófagos
MGMT
Supervivencia general
Pronóstico
Infiltración tumoral linfocitos
id UPSJ_2101da5473e53b620f01119e49f11d1e
oai_identifier_str oai:repositorio.upsjb.edu.pe:upsjb/2646
network_acronym_str UPSJ
network_name_str UPSJB-Institucional
repository_id_str .
dc.title.es_PE.fl_str_mv Distribution of tumor-infiltrating immune cells in glioblastoma
title Distribution of tumor-infiltrating immune cells in glioblastoma
spellingShingle Distribution of tumor-infiltrating immune cells in glioblastoma
Castaneda, Carlos A.
Biomarcador
Glioblastoma
Macrófagos
MGMT
Supervivencia general
Pronóstico
Infiltración tumoral linfocitos
title_short Distribution of tumor-infiltrating immune cells in glioblastoma
title_full Distribution of tumor-infiltrating immune cells in glioblastoma
title_fullStr Distribution of tumor-infiltrating immune cells in glioblastoma
title_full_unstemmed Distribution of tumor-infiltrating immune cells in glioblastoma
title_sort Distribution of tumor-infiltrating immune cells in glioblastoma
author Castaneda, Carlos A.
author_facet Castaneda, Carlos A.
author_role author
dc.contributor.author.fl_str_mv Castaneda, Carlos A.
dc.subject.es_PE.fl_str_mv Biomarcador
Glioblastoma
Macrófagos
MGMT
Supervivencia general
Pronóstico
Infiltración tumoral linfocitos
topic Biomarcador
Glioblastoma
Macrófagos
MGMT
Supervivencia general
Pronóstico
Infiltración tumoral linfocitos
description Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor- infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4 + was as- sociated with unmethylated MGMT (p = 0.016). Higher CD8 + was associated with larger tumoral size (p = 0.027). Higher CD163 + was associated with higher age (p = 0.044) and recursive partitioning anal- ysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4 + (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2020-03-27T22:33:24Z
dc.date.available.none.fl_str_mv 2020-03-27T22:33:24Z
dc.date.issued.fl_str_mv 2018
dc.type.es_PE.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv http://repositorio.upsjb.edu.pe/handle/upsjb/2646
url http://repositorio.upsjb.edu.pe/handle/upsjb/2646
dc.language.iso.es_PE.fl_str_mv eng
language eng
dc.rights.es_PE.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.*.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/3.0/us/
eu_rights_str_mv openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 United States
http://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.format.es_PE.fl_str_mv application/pdf
dc.publisher.es_PE.fl_str_mv CNS Oncology
dc.publisher.country.none.fl_str_mv PE
dc.source.es_PE.fl_str_mv Universidad Privada San Juan Bautista
Repositorio institucional - UPSJB
dc.source.none.fl_str_mv reponame:UPSJB-Institucional
instname:Universidad Privada San Juan Bautista
instacron:UPSJB
instname_str Universidad Privada San Juan Bautista
instacron_str UPSJB
institution UPSJB
reponame_str UPSJB-Institucional
collection UPSJB-Institucional
bitstream.url.fl_str_mv http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/3/license.txt
http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/2/license_rdf
http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/1/PI-FCSM-Carlos%20A%20Castaneda2.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
bb87e2fb4674c76d0d2e9ed07fbb9c86
20f9a692a9280434313decc2691e145a
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Universidad Privada San Juan Bautista
repository.mail.fl_str_mv repositoriovirtual@upsjb.edu.pe
_version_ 1743520006162874368
spelling Castaneda, Carlos A.2020-03-27T22:33:24Z2020-03-27T22:33:24Z2018http://repositorio.upsjb.edu.pe/handle/upsjb/2646Aim: Evaluation of features related to infiltrating immune cell level in glioblastoma. Methods: Tumor- infiltrating lymphocytes (TILs) through H&E staining, and TILs (CD3, CD4, CD8 and CD20) and macrophage (CD68 and CD163) levels through immunohistochemistry were evaluated through digital analysis. Results: CD68 (9.1%), CD163 (2.2%), CD3 (1.6%) and CD8 (1.6%) had the highest density. Higher CD4 + was as- sociated with unmethylated MGMT (p = 0.016). Higher CD8 + was associated with larger tumoral size (p = 0.027). Higher CD163 + was associated with higher age (p = 0.044) and recursive partitioning anal- ysis = 4. Women (p < 0.05), total resection (p < 0.05), MGMT-methylation (p < 0.001), radiotherapy (p < 0.001), chemotherapy (p < 0.001) and lower CD4 + (p < 0.05) were associated with longer overall survival. Conclusion: Macrophages are more frequent than TILs. Some subsets are associated with clinical features.Submitted by Manuel Cabrera (manuel.cabrera@upsjb.edu.pe) on 2020-03-27T22:33:24Z No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: bb87e2fb4674c76d0d2e9ed07fbb9c86 (MD5) PI-FCSM-Carlos A Castaneda2.pdf: 1932506 bytes, checksum: 20f9a692a9280434313decc2691e145a (MD5)Made available in DSpace on 2020-03-27T22:33:24Z (GMT). No. of bitstreams: 2 license_rdf: 1232 bytes, checksum: bb87e2fb4674c76d0d2e9ed07fbb9c86 (MD5) PI-FCSM-Carlos A Castaneda2.pdf: 1932506 bytes, checksum: 20f9a692a9280434313decc2691e145a (MD5) Previous issue date: 2018application/pdfengCNS OncologyPEinfo:eu-repo/semantics/openAccessAttribution-NonCommercial-NoDerivs 3.0 United Stateshttp://creativecommons.org/licenses/by-nc-nd/3.0/us/Universidad Privada San Juan BautistaRepositorio institucional - UPSJBreponame:UPSJB-Institucionalinstname:Universidad Privada San Juan Bautistainstacron:UPSJBBiomarcadorGlioblastomaMacrófagosMGMTSupervivencia generalPronósticoInfiltración tumoral linfocitosDistribution of tumor-infiltrating immune cells in glioblastomainfo:eu-repo/semantics/articleLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81232http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/2/license_rdfbb87e2fb4674c76d0d2e9ed07fbb9c86MD52ORIGINALPI-FCSM-Carlos A Castaneda2.pdfPI-FCSM-Carlos A Castaneda2.pdfapplication/pdf1932506http://repositorio.upsjb.edu.pe/bitstream/upsjb/2646/1/PI-FCSM-Carlos%20A%20Castaneda2.pdf20f9a692a9280434313decc2691e145aMD51upsjb/2646oai:repositorio.upsjb.edu.pe:upsjb/26462022-01-06 19:10:28.781Universidad Privada San Juan Bautistarepositoriovirtual@upsjb.edu.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
score 13.888049
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).